A simple and fast HPLC method for the determination of ροφΗγπηβ in bile without extraction is described. ΡθφΗγΗη8 were determined in bile from control subjects and from patients after orthotopic liver transplantation, ineluding three patients with eiythropoietic protoporphyria. It was found that: 1) coproporphyrin I is the predominant porphyrin in bile of controls, accompanied by some coproporphyrin III and protoporphyrin, whereas protoporphyrin mostly but not always is the predominant porphyrin in the bile of erythropoietic protoporphyria patients. In two of the three erythropoietic protoporphyria patients, the bile contained a hundred times more protoporphyrin than that of ήοη-porphyric orthotopic liver transplantation patients. The third erythropoietic protpporphyria patient remained cholestatic and was unable to excrete sufficient amounts of protoporphyrin.
Introduction
The poφhyric diseases can be identified by profiling of urine, faeces or blood (1) (2) (3) , and detecting the ροφίν/-Determination of ροφίι^η profiles in biological sain-rins that are ffQ^y elevated. Thus, together with their plesbyrneansofHPLChasprovedvaluableinthediag-clinical presentation, congenital erythropoietic pornosis and treatment of patiemts suffering from currently phyria, poφhyria cutanea tarda and attacks of acute inknownforms ofpoφhyria, allcausedby adeficiency or termittent poφhyria can be identified by analysis of Inhibition of enzymes involved in the synthesis of haem. urine, whereas stool analysis is needed to identify at-tacks of hereditary coproporphyria and variegate porphyria. Erythropoietic protoporphyria can be confirmed by analysis of the protoporphyrin content of erythrocytes. In many clinical laboratories, such determinations are presently performed on a routine basis.
So far, not much attention has been paid to porphyrin profiles in human bile, since the diagnosis and follow up of porphyria can be satisfactorily carried out by analysing urine, faeces or blood. However, for asymptomatic patients with porphyria those methods are not always sufficiently discriminatory. Bile was recently successfully used for the evaluation of asymptomatic patients with variegate porphyria (4) . For some weeks following orthotopic liver transplantation, which is a regulär Operation in our hospital, bile is removed via a T-drain. For the following reasons, we decided to exploit this ready source, in order to determine the porphyrin composition of bile. First, the HPLC method, practised in our laboratory for the specific determination of porphyrins, ahalyses a wide variety of biological samples, using simple and essentially similar purification Steps. Therefore we expected no problems in adapting the method for the analysis of bile. Secondly, three of the many patients underwent transplantation following liver failure due to longstanding erythropoietic protoporphyria. In this disease protoporphyrin is produced in abnormal amounts, mainly in erythrocytes and also in liver, due to ferrochelatase deficiency. The hydrophobic protoporphyrin molecules accumulate in the liver and have to be removed by excretion in bile. Although protoporphyrin is potentially toxic, most erythropoietic protoporphyria patients manage to preserve a reasonable liver fiinction, because the raised quantity of produced protoporphyrin can still be adequately excreted in the bile. However, after the gradual accumulation of protoporphyrin, some erythropoietic protoporphyria patients suffer from irreversible liver damage and finally liver failure, requiring orthotopic liver transplantation in order to survive (5-10). After transplantation, the patients have to be monitored regularly for the ability of the liver to adequately excrete the continuing excessive production of protoporphyrin from bone marrow, because of the risk of renewed liver failure (9) . For these reasons we considered it of clinical interest to compare the biliary excretion of porphyrins of erythropoietic protoporphyria patients in the weeks after orthotopic liver transplantation with that of orthotopic liver transplantation patients operated for liver failure from other diseases.
Further we had at our disposal a number of samples from different patients after duodenal intubation, i. e. A bile (fasting duodenal content), B (gall bladder) bile and C (hepatic) bile. The porphyrin profiles of these samples were investigated and compared with bile from orthotopic liver transplantation patients.
Since none of the bile samples contained traces of porphyrins derived frorn the bacterial conversion ofendogenous porphyrins in the gut (i. e. secondary porphyrins like meso-, pempto-and deuteroporphyrin (3)), we reinvestigated the controversial issue of the existence of an enterohepatic cireulation for porphyrins (11 -14) . For this purpose large amounts of bile and serum were purified for analysis of porphyrins. These concentrated extracts were investigated for the presence of secondary porphyrins, but these appeared to be absent. As discussed in this päper, this does not support the hypothesis that dicarboxylic porphyrins, including protoporphyrin, are subject to enterohepatic cireulation from the lower gastrointestinal tract. Altogether the results of HPLC porphyrin profiling in human bile described in this paper confirm that such determinations constitute a useM extension of the available procedures for pofphyrm profiling in clinical laboratories in certain clinical conditions.
Materials and Methods

Patients and samples
Porphyrins were studied in the bile of two different groups of patients. The first group of six subjects had undergone an orthotopic liver transplantation, three of thera on account of erythropoietic protoporphyria. The second group consisted of 11 subjects who for different reasons were intubated for gall bladder investigations. The orthotopic liver transplantation procedure in our hospital has been described earlier (15) . The biliary procedure was ari end-to-end choledochocholedochostomy over a bile-tube and removal of the gall bladder. After 3-4 weeks, or later if indicated, the tube was clamped, then removed after some days.
The intubation procedure to obtain A-, B-, and C-bile was described previously (16) . The intubation was performed in patients who had fasted for at least 14 hours; a plastic tube with a metallic end was positioned in the third part of the duodenum, using fluoroscopic monitoring. A-bile (fasting duodenal contents, consisting of secretions from the pancreas, bile ducts and duodenum) was aspirated, whereafter contraction of the gall bladder was stimuläted by intravenous administration of cholecystokinin. Within 10-15 minutes after the injection, dark gall bladder bile was aspirated (ß-bile). After 45 to 60 minutes a third sample of light-coloured aspirate was drawn (C-bile). This C-bile consists mainly of hepatic bile with pancreatic and duodenal secretions (16) .
Bile samples of the patients were obtained with regard to the rules of the Medical Ethical Committee of our hospital. The samples were protected from light äs much äs possible and were stored frozen without preservation prior to analysis.
Porphyrin analysis
Bile Two-hundred of bile, 200 of 3 mol/1 HC1 and 100 of an internal Standard solution (500 nmol/1 deuteroporphyrin (Porphyrin Products, Logan, USA) in a 0.8 rnol/1 sülphosalicylic acid solution) were mixed in an Eppendorf cup. After centrifugation, 40 of the clear supernatant was injeeted onto the HPLC column.
The porphyrins of bile were eluted under the same conditions äs porphyrins of urine, blood and faeces. Details of these methods including the use of internal Standard were described previously (2,3).
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During the development of the determination of porpbyrins in bile ihe sample volume and its predil tions were chosen so that normal bile samples give peak heights comparable to those seen in normal urine, blood and faecal samples.
Traces in bile
For the determination of traces of porphyrins in bile the following procedure was used. A bile solution of 100 ml, obtained from fractions of bile of different subjects, was divided into two equal portions. To one portion the internal Standard deuteropoφhyrin was added. Porphyrins were extracted twice with 100 ml of a freshly prepared ether -glacial acetic acid solution (3 4-l, by vol.). In a waterbath set at 37 °C the extracts were evaporated to dryness by means of a nitrogen stream. The poφhyrins were dissolved in l ml of 6 mol/1 HC1 solution, and 40 μΐ of the acid solution was injected onto the HPLC cohimn.
Traces in serum
Due to the low ροφηνπη and high protein concentrations in serum compared with bile, the ροφηνπη extraction procedure for serum completely differs from that of bile. The porphyrins were extracted according to a combination of methods described by Falk (17) . Briefly, a portion of 200 ml serurn, pooled trom more than 50 different subjects, was divided into two equal portions. To one portion the internal Standard deuteropoφhyrin was added. To the sera a tnixture of 500 ml of ethyl acetate and glacial acetic acid (3 + l, by vol.) was added slowly with vigorous stirring and the mixtures were allowed to stand for three hours. The precipitated proteins were removed on a B chner funnel, and washed well two times with 100 ml of an ethyl acetate -acetic acid mixture (3+1, by vol.). The protein residues may still contain considerable amounts of ωΌροφηνπηε, but since we were concerned only with tetra-and dicarboxyiic ροφηντίη8 ηο further attention was paid to the ιίΓοροφηνπηε. The combined filtrates were transferred to a separating funnel, and washed twiee with 300 ml of a saturated sodium acetate solution. The washings were extracted twice with 100 ml of ethyl acetate. The ethyl acetate layers were added to the main ethyl acetate -acetic acid layers. The combined ethyl acetate layers were washed once with 100 ml of 0.2 mol/1 sodium acetate solution. The ροφηνπηβ were extracted completely from the ethyl acetate -acetic acid solution with 2 portions of 50 ml f a 4 mol/1 HC1 solution. In a separating funnel the ροφ!τνπη8 were transferred from the combined HC1 extract into 500 ml ether by adjusting the pH to about 4 with a solution of 4 rool/1 NaOH and 50 ml of a saturated sodimn acetate solution. The mixture was shaken frequently thus preventing precipitation of ροφηνπη$. The aqueous layers were re-extracted twice with fresh ether, and the ether fractions were combined. The combined ether layers were washed once with 100 ml of 0.2 mol/1 sodiurn acetate solution, arid their volumes were reduced by 95% under a nitrogen stream. The ροφίννπηβ were extracted in 500 μΐ of 6 mol/1 HC1, and 200 μΐ of this solution was injected onto the HPLC columii.
Reproducibility, linearity and recovery
The intra-rassay coefficient of Variation of the method was deter-m ined with bile containing normal οορΓοροφΙ^πη Ι and III concentrations and a high content of ρΓΟίοροφΙ^πη (2.5 μηηοΐ/ΐ). This sample was assayed 10 times in the same run. The linearity of the method was determined by analysing two biles with a high ΰορΓοροφηντίη I and ρίοίοροφηντΐη content, respectively, in increasing volumes (10, 20, 50 , 100, 200, 300, and 400 μΐ) to which 100 μΐ of internal Standard and HC1 solution (3 mol/1) were added to an end volurne of 600 μΐ. The recoveries of οορΓοροφΙιν-rin I and ρπΛοροφηντίη were determined in normal bile fortified with 100 and 30 nmol/J, respectively.
Results
Chromatograms of bile porphyrins after orthotopic liver transplantation are shown in figure l (la and Ic, nonerythropoietic protoporphyria patients; Ib and Id, a single patient at different times after orthotopic liver transplantation). The following porphyrins were found to be present in bile: coproporphyrin I and III (peaks numbered l and 2) and protoporphyrin (peak 4). Clearly the erythropoietic protoporphyria patient excretes considerably more protoporphyrin in bile. From figure l, one can further deduce that bile contains no pempto-, and mesoporphyrin (peaks numbered 7 and 8), while deuteroporphyrin (peak 3) also appeared to be absent when omitted s an internal Standard (not shown in fig. 1 ). In order to ascertain that bile and serum contained not even traces of these porphyrins, we concentrated normal bile and serum extracts about fifty to two hundred times (compared with routine procedures) and injected these extracts onto the HPLC column. The results of these experiments are shown in figure 2 (2a: bile with, 2b: bile without internal Standard, 2c: serum with internal Standard, 2d: plain serum) and they demonstrate again that no traces of deutero-, pempto-, and mesoporphyrin are present in bile or serum. There is therefore no objection taking deuteroporphyrin s the internal Standard for the determination of biliary porphyrins. Figures l and 2 show that peaks (numbered 5 and 6) of unknown compounds are also found, eluting between copro-and deuteroporphyrin. Investigation of many other bile samples revealed that the peak heights of these unknown compounds did not correlate with those of protoporphyrin (see for example the chromatograms shown in fig. 1 Because of their porphyric-like fluorescence it is tempting to speculate that these unknown compounds possess a porphyrin structure. Although of potential clinical interest, we have not attempted to study further the nature of the compounds represented by these peaks. are still alive three years after orthotopic liver transplantation). Figures 3c and 3d depict results of three orthotopic liver transplantation subjects, who were transplanted because of primary biliary cirrhosis (n = 1), chronic active (n = 1) and inactive cirrhosis (n = 1). Table l presents a survey of the resuits of porphyrin concentrations in A^, B-, and C-bile of a nurnber of patients.
The coefficients of Variation for intra-nm precisions measured for coproporphyrin I, coproporphyrin ΙΠ and protoporphyrin were 2.1, 5.3 and 1.1% (n = 10), respectively. The method was linear up to 4 μιηοΐ/l for all porphyrins, while recoveries for coproporphyrin I and protopoiphyrin were > 95%.
Discussion
Reports of determinations of porphyrins in bile are scanty, partly due to the fact that bile is not easily available and partly because nalysis of bile is not essential for the diagnosis and follow up of porphyric patietits. However, in a recent report, the nalysis of porphyrins in bile proved to be superior to the nalysis in faeces in establishing the diagnosis of variegate porphyria, s the difference between normal and pathological porphyrin excretions in bile was greater than in faeces (4). Moreover, investigation of biliary porphyrins provides inform ation on the ability of the liver to excrete the different porphyrins. In contrast to uro-and coproporphyrins, highly hydrophobic protopoφhyrin can only be excreted in bile, hepatic secretion being rate limiting (19) . In the case of erythropoietic protoporphyria, the increased blood protopoφhyrin tends to accumul te in the liver, which firstly can lead to cholestasis and eventually t <0.5 6 6 0 terminal liver failure, requiring orthotopic liver transplantation for survival. The fact that bile can be obtained from orthotopic liver transplantation patients during the first weeks after the Operation enabled us to compare the biliary porphyrin excretion, in particular of orthotopic liver transplantation, of three transplanted erythropoietic protoporphyria patients with that of some non-erythropoietic protoporphyria patients. As shown by the chromatograms in figure l and the quantitative data in figure  3 (time course of porphyrin concentrations in the bile of 3 erythropoietic protoppiphyria patients and 3 non^· erythropoietic protoporphyria patients after orthotopic liver transplantation), biliary protoporphyrin is always much higher in erythropoietic protoporphyria patients than in non-erythropoietic protoporphyria patients (in quantitative terms rnore than a hundred fold), whereas biliary coproporphyrin l and III excretion in erythropoietic protoporphyria patients is only slightly higher. These results clearly dempnstrate that in erythropoietic protoporphyria the high amounts of protoporphyrin mainly originate from the eiythropoietic System in bone marrow. Fig re 3 also shows that in the first 5 days after orthotopic liver transplantation both copropoiphyrins and protoporphyrin are excreted in huge amounts, which then retura to very low values, later tending to rise somewhat again. The reason for the strikingly raised biliaiy porphyrin excretion in the first days after orthotopic liver transplantation cannot be given with certainty and is the subject of further study. It might be ascribed to the accumulation of porphyrins produced in the donor liver in the period between its removal and the time that transplantation took place and/or to the accumulation of porphyrins in the host during the Operation phase. After transplantation these accumulated porphyrins could then be washed out. After approximately 5 days, a new steady state Situation is attained, in which the production and excretion of porphyrins match again, and this washout would no longer occur. To our knowledge, porphyrins are the only compounds excreted in highly increased amounts immediately after orthotopic liver transplantation (15) .
During the 5-15 days after orthotopic liver transplantation a temporary difficulty in excretion of porphyrins might be the case, or a low porphyrin de novo synthesis due to liver regeneration, thus explaining the relatively low biliary excretion of porphyrins in that period. However, in two of the three erythropoietic protoporphyria patients, 10-15 days after orthotopic liver transplantation, protoporphyrin values show a sustained rise to very high levels, which vary greatly in individual patients from day to day.
The third erythropoietic protoporphyria patient (see fig.  3 ) continuously excreted considerably less protoporphyrin than the other two erythropoietic protoporphyria patients, despite high protoporphyrin concentrations in blood (15 μηιοΐ/ΐ, normal < 0.56 μηιοΙ/1). Also his protoporphyrin concentrations in serum were increased (data not shown), reflecting the absence of good liver function (18) . He had severe cholesterasis and died half a year after orthotopic liver transplantation. Retrospectively it can be stated that even from the Start of orthotopic liver transplantation he probably had difficulties in adeq ately excreting protoporphyrin, leading to an accumulation of protoporphyrin, which in turn contributed to early liver failure (18) . Protoporphyrin was undetectable in the serum of the other orthotopic liver transplantation patients and the other two erythropoietic protoporphyria patients, using our method, which has a detection limit of < 0.5 nmol/1 (data not shown).
The complete absence of deutero-, pempto-and mesoporphyrins in the bile of orthotopic liver transplantation patients (see fig. 1 ) s well s in A-, B-and C-bile (chromatograms not shown) motivated us to investigate the question of whether or not an enterohepatic circulation of porphyrins operates in humans. These latter porphyrins are produced in the gut s a result of reductive conversion of protoporphyrin by anaerobic bacteria and are markedly present in faeces (3, 19, 20) . If an enterohepatic circulation exists, there should be evidence of these "seeondary" porphyrins in serum and bile, analogous to the presence of secondary bile acids (deoxycholic acid and lithocholic acid) in serum and bile, produced in the gut by bacterial conversion of primary bile acids (cholic acid and chenodeoxycholic acid). In the literature the enterohepatic circulation of porphyrins constitutes a controversial issue. Some reports state that such a circulation exists (11) (12) (13) , whereas others state the reverse (14) . It might be that secondary porphyrins are present in bile or serum in trace amounts. To exclude this possibility we worked up portions of 50 ml of collected bile and 100 ml of pooled serum, each with and withqut internal Standard (deuteroporphyrin). As figures 2a-d demonstrate, even in the concentrated extracts of bile and serum no traces of secondary porphyrins could be detected, which does not support the hypothesis that porphyrins are subject to enterohepatic circulation at the lower part of the gastrointestinal tract. This finding does not exclude the presence of an enterohepatic circulation of copro-and uroporphyrins nor the absorption of protoporphyrifi · at the upper part of the gut. In one of our previous studies it was demonstrated that in normal subjects more than 90% of the primary porphyrins in faeces (protoporphyrin and coproporphyrins) and all of the secondary porphyrins are synthesized by bacteria in the lower part of the small bowel and colon (3). Since dicarboxylic porphyrins are not absorbed in these parts, the total enterohepatic circulation of porphyrins at the upper part of the gastrointestinal tract, if existent, would be relatively small under normal conditions, due to the low biliary concentrations of porphyrins.
Finally, we analysed the porphyrin composition of A-, B-and C-bile from various patients not suffering from any of the porphyrias (see tab. 1). First of all, it is obvious that the concentration of porphyrins in these bile samples varies widely. The patterhs of A-, B-and Cbile, which show close resemblance with those of bile obtained ftom (non-erythropoietic protoporphyria) orthotopic liver transplantation patients, are not essentially different, although the liiean coficentrations in B-bile are higher than in A-and C-bile. Apart from two unknown compounds ("peaks 5 and 6") coproporphyrins I and III, and protoporphyrin are present. Coproporphyrin I is almost always the prominent biliary porphyrin and its eoiicentration far exceeds that of protoporphyrin, the latter not exceeding a value of approximately 30 nmol/1. The overall mean ratios coproporphyrin I/coproporphyrin I and ΠΙ (copro I ratio) and coproporphyrin I/protoporphyrin are 0.76 and 21, respectively. The same results in bile have been previously reported (21, 22) . Similar copro I ratios also are detected in faeces (2, 22) . Only in one case was a copro I ratio of less than 0.50 (coproporphyrin ΙΙί concentration exceeding that of coproporphyrin I) found. In contrast to bile, normal faecal protoporphyrin concentrations (and its derivatives deutero-, pempto-and ^ε$οροφ1ι;ντίη) often markedly exceed those of coproporphyrin I. This can be attributed to both bacterial prod ction and conversion of protoporphyrin in the gut (3, 19, 20) .
To summarize, the profiling of porphyrins in bile reveals interesting aspects of their hepatic clearance, and shows that their quantitative determination can be of value in some clinical situations, e.g. the follow up of protoporphyrin excretion in erythropoietic protoporphyria patients after orthotopic liver transplantation. The absence of secondary porphyrins in bile (and serum) suggests the absence of an enterohepatic circulation for dicarboxylic porphyrins.
